Supernus Pharmaceuticals, Inc. (SUPN) · Insider trading
What Supernus Pharmaceuticals's directors, officers and largest holders bought and sold themselves, from the Form 4 each of them files with the SEC within two business days of a trade. Open-market purchases and sales first: those are the trades somebody chose to make at the market price.
Bought, 12 months
$0
0 insiders, 0 trades
Sold, 12 months
$10.26M
7 insiders, 82% under a plan
Net, 12 months
−$10.26M
bought less sold
Latest filing
2026-08-14
filings read to 2026-10-19
Who traded, two years
| Insider | Bought | Sold | Trades | Last trade | Holds after |
|---|---|---|---|---|---|
| Khattar Jack A.Director, President, CEO | – | $29.43M | 22 | 2026-03-13 | – |
| Bhatt Padmanabh P.Sr. VP of IP, CSO | – | $6.71M | 12 | 2026-03-18 | 17,456 |
| Mottola FrankSVP, Chief Tech. Ops. Officer | – | $2.50M | 6 | 2026-03-09 | 18,440 |
| Newhall Charles W IIIDirector | – | $1.93M | 6 | 2025-10-09 | 105,844 |
| Gemayel GeorgesDirector | – | $1.91M | 4 | 2026-03-06 | 27,277 |
| Hudson Frederick M.Director | – | $903,292 | 3 | 2026-03-12 | 60,413 |
| Dec Timothy CSenior Vice-President & CFO | – | $524,092 | 1 | 2025-08-22 | 1,246 |
| Horich William ToddSVP, Commercial Operations | – | $483,797 | 2 | 2026-03-10 | 0 |
| Sensenig BethanyDirector | – | $455,105 | 3 | 2026-02-19 | 3,258 |
| Rubin JonathanSVP, Chief Medical Officer | – | $36,292 | 1 | 2025-02-21 | 7,853 |
Open-market purchases and sales
Newest first. “Plan” marks a trade made under a 10b5-1 plan set up in advance.
| Date | Insider | Trade | Shares | Price | Value | Holds after | Filing |
|---|---|---|---|---|---|---|---|
| 2026-03-18 | Bhatt Padmanabh P.Sr. VP of IP, CSO | Saleplan | 6,838 | 49.55 | $338,823 | 17,456 | Form 4 |
| 2026-03-18 | Bhatt Padmanabh P.Sr. VP of IP, CSO | Saleplan | 412 | 50.48 | $20,798 | 17,044 | Form 4 |
| 2026-03-17 | Bhatt Padmanabh P.Sr. VP of IP, CSO | Saleplan | 27,710 | 49.95 | $1.38M | 39,334 | Form 4 |
| 2026-03-17 | Bhatt Padmanabh P.Sr. VP of IP, CSO | Saleplan | 22,290 | 50.73 | $1.13M | 17,044 | Form 4 |
| 2026-03-16 | Bhatt Padmanabh P.Sr. VP of IP, CSO | Saleplan | 34,114 | 50.18 | $1.71M | 32,930 | Form 4 |
| 2026-03-16 | Bhatt Padmanabh P.Sr. VP of IP, CSO | Saleplan | 15,886 | 50.49 | $802,084 | 17,044 | Form 4 |
| 2026-03-13 | Khattar Jack A.Director, President, CEO | Saleplanindirect | 24,138 | 50.09 | $1.21M | 968,962 | Form 4 |
| 2026-03-13 | Khattar Jack A.Director, President, CEO | Saleplanindirect | 10,742 | 51.00 | $547,842 | 958,220 | Form 4 |
| 2026-03-13 | Khattar Jack A.Director, President, CEO | Saleplanindirect | 120 | 51.75 | $6,210 | 958,100 | Form 4 |
| 2026-03-12 | Hudson Frederick M.Director | Sale | 5,369 | 50.61 | $271,725 | 60,413 | Form 4 |
| 2026-03-10 | Horich William ToddSVP, Commercial Operations | Sale | 4,439 | 55.00 | $244,145 | 0 | Form 4 |
| 2026-03-09 | Mottola FrankSVP, Chief Tech. Ops. Officer | Sale | 1,623 | 53.65 | $87,074 | 18,440 | Form 4 |
| 2026-03-09 | Horich William ToddSVP, Commercial Operations | Sale | 4,438 | 54.00 | $239,652 | 4,439 | Form 4 |
| 2026-03-06 | Gemayel GeorgesDirector | Sale | 8,787 | 53.00 | $465,711 | 27,277 | Form 4 |
| 2026-03-05 | Gemayel GeorgesDirector | Sale | 10,000 | 53.71 | $537,100 | 28,159 | Form 4 |
| 2026-02-19 | Sensenig BethanyDirector | Saleplan | 1,217 | 50.31 | $61,227 | 3,258 | Form 4 |
| 2026-02-19 | Sensenig BethanyDirector | Saleplan | 3,258 | 51.27 | $167,038 | 0 | Form 4 |
| 2025-12-19 | Mottola FrankSVP, Chief Tech. Ops. Officer | Saleplan | 5,000 | 50.22 | $251,100 | 15,496 | Form 4 |
| 2025-12-19 | Mottola FrankSVP, Chief Tech. Ops. Officer | Saleplan | 15,000 | 50.47 | $757,050 | 15,496 | Form 4 |
| 2025-12-18 | Bhatt Padmanabh P.Sr. VP of IP, CSO | Sale | 710 | 44.44 | $31,552 | 14,508 | Form 4 |
| 2025-10-09 | Newhall Charles W IIIDirector | Saleplan | 23,800 | 50.73 | $1.21M | 105,844 | Form 4 |
| 2025-10-09 | Newhall Charles W IIIDirector | Saleplan | 1,200 | 51.55 | $61,860 | 104,644 | Form 4 |
| 2025-10-09 | Khattar Jack A.Director, President, CEO | Saleplan | 58,371 | 50.55 | $2.95M | 1,208,107 | Form 4 |
| 2025-10-09 | Khattar Jack A.Director, President, CEO | Saleplan | 1,529 | 51.46 | $78,682 | 1,206,578 | Form 4 |
| 2025-10-02 | Khattar Jack A.Director, President, CEO | Saleplan | 1,904 | 48.06 | $91,506 | 1,161,233 | Form 4 |
| 2025-10-01 | Khattar Jack A.Director, President, CEO | Saleplan | 40,173 | 48.07 | $1.93M | 1,160,870 | Form 4 |
| 2025-09-30 | Khattar Jack A.Director, President, CEO | Saleplan | 8,588 | 48.25 | $414,371 | 1,147,258 | Form 4 |
| 2025-09-29 | Khattar Jack A.Director, President, CEO | Saleplan | 10,235 | 48.02 | $491,485 | 1,144,336 | Form 4 |
| 2025-09-23 | Khattar Jack A.Director, President, CEO | Saleplan | 29,513 | 47.23 | $1.39M | 1,140,883 | Form 4 |
| 2025-09-22 | Khattar Jack A.Director, President, CEO | Saleplan | 16,587 | 47.02 | $779,921 | 1,122,456 | Form 4 |
| 2025-09-12 | Mottola FrankSVP, Chief Tech. Ops. Officer | Sale | 5,000 | 45.87 | $229,350 | 15,496 | Form 4 |
| 2025-09-08 | Khattar Jack A.Director, President, CEO | Saleplan | 6,322 | 46.29 | $292,645 | 1,111,983 | Form 4 |
| 2025-09-05 | Khattar Jack A.Director, President, CEO | Saleplan | 55,578 | 46.01 | $2.56M | 1,110,231 | Form 4 |
| 2025-08-28 | Khattar Jack A.Director, President, CEO | Saleplan | 24,150 | 45.12 | $1.09M | 1,092,633 | Form 4 |
| 2025-08-27 | Newhall Charles W IIIDirector | Saleplan | 3,588 | 45.01 | $161,496 | 129,644 | Form 4 |
| 2025-08-27 | Khattar Jack A.Director, President, CEO | Saleplan | 10,650 | 45.05 | $479,782 | 1,078,004 | Form 4 |
| 2025-08-25 | Newhall Charles W IIIDirector | Saleplan | 1,000 | 45.00 | $45,000 | 133,232 | Form 4 |
| 2025-08-25 | Khattar Jack A.Director, President, CEO | Saleplan | 1,000 | 45.00 | $45,000 | 1,071,459 | Form 4 |
| 2025-08-25 | Mottola FrankSVP, Quality, GMP, Ops, IT | Sale | 14,000 | 44.51 | $623,140 | 15,496 | Form 4 |
| 2025-08-22 | Newhall Charles W IIIDirector | Saleplan | 1,412 | 45.00 | $63,540 | 134,232 | Form 4 |
20 more
| 2025-08-22 | Dec Timothy CSenior Vice-President & CFO | Sale | 11,780 | 44.49 | $524,092 | 1,246 | Form 4 |
| 2025-08-22 | Khattar Jack A.Director, President, CEO | Saleplan | 1,500 | 45.00 | $67,500 | 1,070,848 | Form 4 |
| 2025-08-14 | Hudson Frederick M.Director | Sale | 7,457 | 42.26 | $315,133 | 46,307 | Form 4 |
| 2025-08-14 | Sensenig BethanyDirector | Saleplan | 5,369 | 42.25 | $226,840 | 0 | Form 4 |
| 2025-08-06 | Khattar Jack A.Director, President, CEO | Saleplan | 38,500 | 40.24 | $1.55M | 1,030,183 | Form 4 |
| 2025-08-06 | Khattar Jack A.Director, President, CEO | Saleplan | 38,000 | 42.00 | $1.60M | 1,052,183 | Form 4 |
| 2025-08-06 | Khattar Jack A.Director, President, CEO | Saleplan | 63,500 | 43.12 | $2.74M | 1,069,933 | Form 4 |
| 2025-02-21 | Rubin JonathanSVP, Chief Medical Officer | Sale | 927 | 39.15 | $36,292 | 7,853 | Form 4 |
| 2025-02-04 | Bhatt Padmanabh P.Sr. VP of IP, CSO | Saleplan | 9,477 | 39.70 | $376,237 | 10,149 | Form 4 |
| 2025-01-28 | Bhatt Padmanabh P.Sr. VP of IP, CSO | Saleplan | 700 | 39.62 | $27,734 | 10,149 | Form 4 |
| 2025-01-27 | Bhatt Padmanabh P.Sr. VP of IP, CSO | Saleplan | 2,573 | 39.62 | $101,942 | 10,149 | Form 4 |
| 2024-12-03 | Bhatt Padmanabh P.Sr. VP of IP, CSO | Saleplan | 8,750 | 36.68 | $320,950 | 9,679 | Form 4 |
| 2024-12-03 | Bhatt Padmanabh P.Sr. VP of IP, CSO | Saleplan | 12,745 | 36.68 | $467,487 | 9,679 | Form 4 |
| 2024-11-11 | Newhall Charles W IIIDirector | Sale | 10,700 | 36.24 | $387,768 | 130,275 | Form 4 |
| 2024-11-08 | Khattar Jack A.Director, President, CEO | Sale | 125,000 | 36.29 | $4.54M | 926,172 | Form 4 |
| 2024-11-08 | Gemayel GeorgesDirector | Sale | 10,787 | 36.30 | $391,568 | 13,315 | Form 4 |
| 2024-11-08 | Hudson Frederick M.Director | Sale | 8,722 | 36.28 | $316,434 | 28,395 | Form 4 |
| 2024-11-07 | Khattar Jack A.Director, President, CEO | Sale | 125,000 | 36.68 | $4.58M | 926,172 | Form 4 |
| 2024-11-07 | Gemayel GeorgesDirector | Sale | 14,213 | 36.62 | $520,480 | 13,315 | Form 4 |
| 2024-11-07 | Mottola FrankSVP, Quality, GMP, Ops, IT | Sale | 15,000 | 36.98 | $554,700 | 8,200 | Form 4 |
Grants, exercises and other transactions
Pay, tax and paperwork rather than a choice to trade at the market price. Two years.
76 × option exercise57 × shares withheld for tax37 × grant or award4 × other
Show them
| Date | Insider | What | Shares | Price | Holds after | Filing |
|---|---|---|---|---|---|---|
| 2026-08-12 | Dec Timothy CSenior Vice-President & CFO | Option exercise M | +1,250 | – | 9,733 | Form 4 |
| 2026-08-12 | Dec Timothy CSenior Vice-President & CFO | Shares withheld for tax F | −604 | 46.57 | 9,129 | Form 4 |
| 2026-08-12 | Bhatt Padmanabh P.Sr. VP of IP, CSO | Option exercise M | +2,500 | – | 19,795 | Form 4 |
| 2026-08-12 | Bhatt Padmanabh P.Sr. VP of IP, CSO | Shares withheld for tax F | −1,158 | 46.57 | 18,637 | Form 4 |
| 2026-08-12 | Khattar Jack A.Director, President, CEO | Option exercise M | +29,849 | – | 1,270,993 | Form 4 |
| 2026-08-12 | Khattar Jack A.Director, President, CEO | Shares withheld for tax F | −12,642 | 46.57 | 1,258,351 | Form 4 |
| 2026-08-12 | Mottola FrankSVP, Chief Tech. Ops. Officer | Option exercise M | +1,650 | – | 20,341 | Form 4 |
| 2026-08-12 | Mottola FrankSVP, Chief Tech. Ops. Officer | Shares withheld for tax F | −797 | 46.57 | 19,544 | Form 4 |
| 2026-08-12 | Rubin JonathanSVP, Chief Medical Officer | Option exercise M | +750 | – | 14,342 | Form 4 |
| 2026-08-12 | Rubin JonathanSVP, Chief Medical Officer | Shares withheld for tax F | −363 | 46.57 | 13,979 | Form 4 |
| 2026-03-18 | Bhatt Padmanabh P.Sr. VP of IP, CSO | Option exercise M | +7,250 | 39.40 | 24,294 | Form 4 |
| 2026-03-17 | Bhatt Padmanabh P.Sr. VP of IP, CSO | Option exercise M | +22,750 | 39.40 | 39,794 | Form 4 |
| 2026-03-17 | Bhatt Padmanabh P.Sr. VP of IP, CSO | Option exercise M | +12,250 | 36.75 | 52,044 | Form 4 |
| 2026-03-17 | Bhatt Padmanabh P.Sr. VP of IP, CSO | Option exercise M | +15,000 | 38.60 | 67,044 | Form 4 |
| 2026-03-16 | Bhatt Padmanabh P.Sr. VP of IP, CSO | Option exercise M | +22,750 | 36.75 | 39,794 | Form 4 |
| 2026-03-16 | Bhatt Padmanabh P.Sr. VP of IP, CSO | Option exercise M | +4,250 | 29.61 | 44,044 | Form 4 |
| 2026-03-16 | Bhatt Padmanabh P.Sr. VP of IP, CSO | Option exercise M | +18,000 | 32.20 | 62,044 | Form 4 |
| 2026-03-16 | Bhatt Padmanabh P.Sr. VP of IP, CSO | Option exercise M | +5,000 | 27.94 | 67,044 | Form 4 |
| 2026-03-13 | Khattar Jack A.Director, President, CEO | Other J | +12,500 | – | 1,241,144 | Form 4 |
| 2026-03-13 | Khattar Jack A.Director, President, CEO | Other J | −12,500 | – | 993,100 | Form 4 |
| 2026-03-06 | Dec Timothy CSenior Vice-President & CFO | Option exercise M | +3,000 | – | 8,115 | Form 4 |
| 2026-03-06 | Dec Timothy CSenior Vice-President & CFO | Shares withheld for tax F | −1,433 | 54.73 | 6,682 | Form 4 |
| 2026-03-06 | Dec Timothy CSenior Vice-President & CFO | Option exercise M | +3,000 | – | 9,682 | Form 4 |
| 2026-03-06 | Dec Timothy CSenior Vice-President & CFO | Shares withheld for tax F | −1,450 | 54.73 | 8,232 | Form 4 |
| 2026-03-06 | Khattar Jack A.Director, President, CEO | Option exercise M | +38,640 | – | 1,245,218 | Form 4 |
| 2026-03-06 | Khattar Jack A.Director, President, CEO | Shares withheld for tax F | −16,574 | 54.73 | 1,228,644 | Form 4 |
| 2026-03-06 | Mottola FrankSVP, Chief Tech. Ops. Officer | Option exercise M | +3,750 | – | 21,856 | Form 4 |
| 2026-03-06 | Mottola FrankSVP, Chief Tech. Ops. Officer | Shares withheld for tax F | −1,793 | 54.73 | 20,063 | Form 4 |
| 2026-03-06 | Horich William ToddSVP, Commercial Operations | Option exercise M | +2,625 | – | 7,457 | Form 4 |
| 2026-03-06 | Horich William ToddSVP, Commercial Operations | Shares withheld for tax F | −1,216 | 54.73 | 6,241 | Form 4 |
| 2026-03-06 | Horich William ToddSVP, Commercial Operations | Option exercise M | +3,750 | – | 9,991 | Form 4 |
| 2026-03-06 | Horich William ToddSVP, Commercial Operations | Shares withheld for tax F | −1,718 | 54.73 | 8,273 | Form 4 |
| 2026-03-06 | Horich William ToddSVP, Commercial Operations | Option exercise M | +1,125 | – | 9,398 | Form 4 |
| 2026-03-06 | Horich William ToddSVP, Commercial Operations | Shares withheld for tax F | −521 | 54.73 | 8,877 | Form 4 |
| 2026-03-06 | Gemayel GeorgesDirector | Option exercise M | +7,905 | 25.30 | 36,064 | Form 4 |
| 2026-02-25 | Dec Timothy CSenior Vice-President & CFO | Grant or award A | +2,500 | – | 6,394 | Form 4 |
| 2026-02-25 | Dec Timothy CSenior Vice-President & CFO | Shares withheld for tax F | −1,279 | 50.69 | 5,115 | Form 4 |
| 2026-02-25 | Bhatt Padmanabh P.Sr. VP of IP, CSO | Grant or award A | +1,250 | – | 17,694 | Form 4 |
| 2026-02-25 | Bhatt Padmanabh P.Sr. VP of IP, CSO | Shares withheld for tax F | −650 | 50.69 | 17,044 | Form 4 |
| 2026-02-25 | Mottola FrankSVP, Chief Tech. Ops. Officer | Grant or award A | +1,875 | – | 19,083 | Form 4 |
| 2026-02-25 | Mottola FrankSVP, Chief Tech. Ops. Officer | Shares withheld for tax F | −977 | 50.69 | 18,106 | Form 4 |
| 2026-02-25 | Rubin JonathanSVP, Chief Medical Officer | Grant or award A | +1,250 | – | 14,016 | Form 4 |
| 2026-02-25 | Rubin JonathanSVP, Chief Medical Officer | Shares withheld for tax F | −675 | 50.69 | 13,341 | Form 4 |
| 2026-02-24 | Newhall Charles W IIIDirector | Grant or award A | +4,475 | – | 124,119 | Form 4 |
| 2026-02-24 | Dec Timothy CSenior Vice-President & CFO | Grant or award A | +1,125 | – | 2,763 | Form 4 |
| 2026-02-24 | Dec Timothy CSenior Vice-President & CFO | Shares withheld for tax F | −603 | 51.35 | 2,160 | Form 4 |
| 2026-02-24 | Dec Timothy CSenior Vice-President & CFO | Grant or award A | +500 | – | 2,660 | Form 4 |
| 2026-02-24 | Dec Timothy CSenior Vice-President & CFO | Shares withheld for tax F | −242 | 50.86 | 2,418 | Form 4 |
| 2026-02-24 | Dec Timothy CSenior Vice-President & CFO | Grant or award A | +3,000 | – | 5,418 | Form 4 |
| 2026-02-24 | Dec Timothy CSenior Vice-President & CFO | Shares withheld for tax F | −1,524 | 50.86 | 3,894 | Form 4 |
| 2026-02-24 | Gemayel GeorgesDirector | Grant or award A | +4,475 | – | 38,159 | Form 4 |
| 2026-02-24 | Hudson Frederick M.Director | Grant or award A | +4,475 | – | 65,782 | Form 4 |
| 2026-02-24 | Bhatt Padmanabh P.Sr. VP of IP, CSO | Grant or award A | +1,125 | – | 16,025 | Form 4 |
| 2026-02-24 | Bhatt Padmanabh P.Sr. VP of IP, CSO | Shares withheld for tax F | −581 | 51.35 | 15,444 | Form 4 |
| 2026-02-24 | Bhatt Padmanabh P.Sr. VP of IP, CSO | Grant or award A | +750 | – | 16,194 | Form 4 |
| 2026-02-24 | Bhatt Padmanabh P.Sr. VP of IP, CSO | Shares withheld for tax F | −354 | 50.86 | 15,840 | Form 4 |
| 2026-02-24 | Bhatt Padmanabh P.Sr. VP of IP, CSO | Grant or award A | +1,250 | – | 17,090 | Form 4 |
| 2026-02-24 | Bhatt Padmanabh P.Sr. VP of IP, CSO | Shares withheld for tax F | −646 | 50.86 | 16,444 | Form 4 |
| 2026-02-24 | Barlow CarroleeDirector | Grant or award A | +4,475 | – | 27,045 | Form 4 |
| 2026-02-24 | Mottola FrankSVP, Chief Tech. Ops. Officer | Grant or award A | +1,125 | – | 16,849 | Form 4 |
| 2026-02-24 | Mottola FrankSVP, Chief Tech. Ops. Officer | Shares withheld for tax F | −603 | 51.35 | 16,246 | Form 4 |
| 2026-02-24 | Mottola FrankSVP, Chief Tech. Ops. Officer | Grant or award A | +750 | – | 16,996 | Form 4 |
| 2026-02-24 | Mottola FrankSVP, Chief Tech. Ops. Officer | Shares withheld for tax F | −368 | 50.86 | 16,628 | Form 4 |
| 2026-02-24 | Mottola FrankSVP, Chief Tech. Ops. Officer | Grant or award A | +1,250 | – | 17,878 | Form 4 |
| 2026-02-24 | Mottola FrankSVP, Chief Tech. Ops. Officer | Shares withheld for tax F | −670 | 50.86 | 17,208 | Form 4 |
| 2026-02-24 | Rubin JonathanSVP, Chief Medical Officer | Grant or award A | +1,125 | – | 12,409 | Form 4 |
| 2026-02-24 | Rubin JonathanSVP, Chief Medical Officer | Shares withheld for tax F | −603 | 51.35 | 11,806 | Form 4 |
| 2026-02-24 | Rubin JonathanSVP, Chief Medical Officer | Grant or award A | +750 | – | 12,556 | Form 4 |
| 2026-02-24 | Rubin JonathanSVP, Chief Medical Officer | Shares withheld for tax F | −369 | 50.86 | 12,187 | Form 4 |
| 2026-02-24 | Rubin JonathanSVP, Chief Medical Officer | Grant or award A | +1,250 | – | 13,437 | Form 4 |
| 2026-02-24 | Rubin JonathanSVP, Chief Medical Officer | Shares withheld for tax F | −671 | – | 12,766 | Form 4 |
| 2026-02-23 | Gemayel GeorgesDirector | Option exercise M | +15,000 | 12.98 | 33,684 | Form 4 |
| 2026-02-19 | Sensenig BethanyDirector | Option exercise M | +4,475 | – | 4,475 | Form 4 |
| 2026-01-09 | Hudson Frederick M.Director | Option exercise M | +15,000 | 12.98 | 61,307 | Form 4 |
| 2025-12-19 | Mottola FrankSVP, Chief Tech. Ops. Officer | Option exercise M | +5,000 | 39.40 | 20,496 | Form 4 |
| 2025-12-19 | Mottola FrankSVP, Chief Tech. Ops. Officer | Option exercise M | +15,000 | 25.30 | 30,496 | Form 4 |
| 2025-12-18 | Bhatt Padmanabh P.Sr. VP of IP, CSO | Option exercise M | +1,500 | – | 15,218 | Form 4 |
| 2025-11-21 | Newhall Charles W IIIDirector | Option exercise M | +15,000 | 12.98 | 119,644 | Form 4 |
| 2025-10-09 | Khattar Jack A.Director, President, CEO | Option exercise M | +81,250 | 25.30 | 1,266,478 | Form 4 |
| 2025-10-02 | Khattar Jack A.Director, President, CEO | Option exercise M | +2,267 | 25.30 | 1,163,137 | Form 4 |
| 2025-10-02 | Khattar Jack A.Director, President, CEO | Option exercise M | +20,000 | – | 1,181,233 | Form 4 |
| 2025-10-02 | Khattar Jack A.Director, President, CEO | Shares withheld for tax F | −7,796 | 46.21 | 1,173,437 | Form 4 |
| 2025-10-02 | Khattar Jack A.Director, President, CEO | Option exercise M | +19,320 | – | 1,192,757 | Form 4 |
| 2025-10-02 | Khattar Jack A.Director, President, CEO | Shares withheld for tax F | −7,529 | 46.21 | 1,185,228 | Form 4 |
| 2025-10-01 | Khattar Jack A.Director, President, CEO | Option exercise M | +53,785 | 25.30 | 1,201,043 | Form 4 |
| 2025-09-30 | Khattar Jack A.Director, President, CEO | Option exercise M | +11,510 | 25.30 | 1,155,846 | Form 4 |
| 2025-09-29 | Khattar Jack A.Director, President, CEO | Option exercise M | +13,688 | 25.30 | 1,154,571 | Form 4 |
| 2025-09-25 | Rubin JonathanSVP, Chief Medical Officer | Option exercise M | +1,875 | – | 11,855 | Form 4 |
| 2025-09-25 | Rubin JonathanSVP, Chief Medical Officer | Shares withheld for tax F | −840 | 46.21 | 11,015 | Form 4 |
| 2025-09-23 | Khattar Jack A.Director, President, CEO | Option exercise M | +47,940 | 12.98 | 1,170,396 | Form 4 |
| 2025-09-22 | Khattar Jack A.Director, President, CEO | Option exercise M | +27,060 | 12.98 | 1,139,043 | Form 4 |
| 2025-09-12 | Mottola FrankSVP, Chief Tech. Ops. Officer | Option exercise M | +5,000 | 39.40 | 20,496 | Form 4 |
| 2025-09-08 | Khattar Jack A.Director, President, CEO | Option exercise M | +8,074 | 25.30 | 1,118,305 | Form 4 |
| 2025-09-05 | Khattar Jack A.Director, President, CEO | Option exercise M | +73,176 | 25.30 | 1,165,809 | Form 4 |
| 2025-08-28 | Khattar Jack A.Director, President, CEO | Option exercise M | +38,779 | 12.98 | 1,116,783 | Form 4 |
| 2025-08-27 | Khattar Jack A.Director, President, CEO | Option exercise M | +17,195 | 12.98 | 1,088,654 | Form 4 |
| 2025-08-25 | Bhatt Padmanabh P.Sr. VP of IP, CSO | Option exercise M | +1,250 | – | 14,299 | Form 4 |
| 2025-08-25 | Bhatt Padmanabh P.Sr. VP of IP, CSO | Shares withheld for tax F | −581 | 41.46 | 13,718 | Form 4 |
| 2025-08-25 | Khattar Jack A.Director, President, CEO | Option exercise M | +1,611 | 12.98 | 1,072,459 | Form 4 |
| 2025-08-25 | Mottola FrankSVP, Quality, GMP, Ops, IT | Option exercise M | +14,000 | 12.98 | 29,496 | Form 4 |
| 2025-08-22 | Khattar Jack A.Director, President, CEO | Option exercise M | +2,415 | 12.98 | 1,072,348 | Form 4 |
| 2025-08-06 | Khattar Jack A.Director, President, CEO | Option exercise M | +60,000 | 12.98 | 1,068,683 | Form 4 |
| 2025-08-06 | Khattar Jack A.Director, President, CEO | Option exercise M | +60,000 | 12.98 | 1,090,183 | Form 4 |
| 2025-08-06 | Khattar Jack A.Director, President, CEO | Option exercise M | +81,250 | 25.30 | 1,133,433 | Form 4 |
| 2025-04-02 | Khattar Jack A.Director, President, CEO | Other J | +16,850 | – | 1,008,683 | Form 4 |
| 2025-04-02 | Khattar Jack A.Director, President, CEO | Other J | −16,850 | – | 1,005,600 | Form 4 |
| 2025-03-10 | Dec Timothy CSenior Vice-President & CFO | Option exercise M | +2,000 | – | 12,898 | Form 4 |
| 2025-03-10 | Dec Timothy CSenior Vice-President & CFO | Shares withheld for tax F | −1,062 | 32.06 | 11,836 | Form 4 |
| 2025-03-10 | Dec Timothy CSenior Vice-President & CFO | Option exercise M | +1,800 | – | 13,636 | Form 4 |
| 2025-03-10 | Dec Timothy CSenior Vice-President & CFO | Shares withheld for tax F | −955 | 32.06 | 12,681 | Form 4 |
| 2025-03-10 | Khattar Jack A.Director, President, CEO | Option exercise M | +35,000 | – | 1,008,638 | Form 4 |
| 2025-03-10 | Khattar Jack A.Director, President, CEO | Shares withheld for tax F | −16,805 | 32.06 | 991,833 | Form 4 |
| 2025-03-07 | Mottola FrankSVP, Quality, GMP, Ops, IT | Option exercise M | +2,625 | – | 16,507 | Form 4 |
| 2025-03-07 | Mottola FrankSVP, Quality, GMP, Ops, IT | Shares withheld for tax F | −1,356 | 39.11 | 15,151 | Form 4 |
| 2025-03-07 | Khattar Jack A.Director, President, CEO | Option exercise M | +38,640 | – | 992,219 | Form 4 |
| 2025-03-07 | Khattar Jack A.Director, President, CEO | Shares withheld for tax F | −18,581 | 39.11 | 973,638 | Form 4 |
| 2025-03-05 | Rubin JonathanSVP, Chief Medical Officer | Shares withheld for tax F | −314 | 33.05 | 10,789 | Form 4 |
| 2025-03-05 | Rubin JonathanSVP, Chief Medical Officer | Shares withheld for tax F | −577 | 33.05 | 10,212 | Form 4 |
| 2025-03-05 | Rubin JonathanSVP, Chief Medical Officer | Shares withheld for tax F | −577 | 33.05 | 9,635 | Form 4 |
| 2025-03-05 | Mottola FrankSVP, Quality, GMP, Ops, IT | Shares withheld for tax F | −337 | 33.05 | 15,437 | Form 4 |
| 2025-03-05 | Mottola FrankSVP, Quality, GMP, Ops, IT | Shares withheld for tax F | −610 | 33.05 | 14,827 | Form 4 |
| 2025-03-05 | Mottola FrankSVP, Quality, GMP, Ops, IT | Shares withheld for tax F | −945 | 33.05 | 13,882 | Form 4 |
| 2025-03-05 | Bhatt Padmanabh P.Sr. VP of IP, CSO | Shares withheld for tax F | −335 | 33.05 | 13,854 | Form 4 |
| 2025-03-05 | Bhatt Padmanabh P.Sr. VP of IP, CSO | Shares withheld for tax F | −575 | 33.05 | 13,279 | Form 4 |
| 2025-03-05 | Bhatt Padmanabh P.Sr. VP of IP, CSO | Shares withheld for tax F | −575 | 33.05 | 12,704 | Form 4 |
| 2025-03-05 | Dec Timothy CSenior Vice-President & CFO | Shares withheld for tax F | −276 | 33.05 | 13,815 | Form 4 |
| 2025-03-05 | Dec Timothy CSenior Vice-President & CFO | Shares withheld for tax F | −1,587 | 33.05 | 12,228 | Form 4 |
| 2025-03-05 | Dec Timothy CSenior Vice-President & CFO | Shares withheld for tax F | −1,330 | 33.05 | 10,898 | Form 4 |
| 2025-02-26 | Mottola FrankSVP, Quality, GMP, Ops, IT | Option exercise M | +2,010 | – | 14,909 | Form 4 |
| 2025-02-26 | Mottola FrankSVP, Quality, GMP, Ops, IT | Shares withheld for tax F | −976 | 39.48 | 13,933 | Form 4 |
| 2025-02-26 | Mottola FrankSVP, Quality, GMP, Ops, IT | Option exercise M | +3,750 | – | 17,683 | Form 4 |
| 2025-02-26 | Mottola FrankSVP, Quality, GMP, Ops, IT | Shares withheld for tax F | −1,909 | 39.48 | 15,774 | Form 4 |
| 2025-02-23 | Dec Timothy CSenior Vice-President & CFO | Grant or award A | +2,500 | – | 14,091 | Form 4 |
| 2025-02-23 | Mottola FrankSVP, Quality, GMP, Ops, IT | Grant or award A | +1,875 | – | 12,899 | Form 4 |
| 2025-02-23 | Rubin JonathanSVP, Chief Medical Officer | Grant or award A | +1,250 | – | 11,103 | Form 4 |
| 2025-02-23 | Bhatt Padmanabh P.Sr. VP of IP, CSO | Grant or award A | +1,250 | – | 14,189 | Form 4 |
| 2025-02-22 | Sensenig BethanyDirector | Grant or award A | +5,369 | – | 5,369 | Form 4 |
| 2025-02-22 | Barlow CarroleeDirector | Grant or award A | +5,369 | – | 22,570 | Form 4 |
| 2025-02-22 | Gemayel GeorgesDirector | Grant or award A | +5,369 | – | 18,684 | Form 4 |
| 2025-02-22 | Newhall Charles W IIIDirector | Grant or award A | +5,369 | – | 135,644 | Form 4 |
| 2025-02-22 | Hudson Frederick M.Director | Grant or award A | +5,369 | – | 53,764 | Form 4 |
| 2025-02-22 | Dec Timothy CSenior Vice-President & CFO | Grant or award A | +500 | – | 8,591 | Form 4 |
| 2025-02-22 | Dec Timothy CSenior Vice-President & CFO | Grant or award A | +3,000 | – | 11,591 | Form 4 |
| 2025-02-22 | Mottola FrankSVP, Quality, GMP, Ops, IT | Grant or award A | +750 | – | 9,774 | Form 4 |
| 2025-02-22 | Mottola FrankSVP, Quality, GMP, Ops, IT | Grant or award A | +1,250 | – | 11,024 | Form 4 |
| 2025-02-22 | Rubin JonathanSVP, Chief Medical Officer | Grant or award A | +750 | – | 8,603 | Form 4 |
| 2025-02-22 | Rubin JonathanSVP, Chief Medical Officer | Grant or award A | +1,250 | – | 9,853 | Form 4 |
| 2025-02-22 | Bhatt Padmanabh P.Sr. VP of IP, CSO | Grant or award A | +750 | – | 11,689 | Form 4 |
| 2025-02-22 | Bhatt Padmanabh P.Sr. VP of IP, CSO | Grant or award A | +1,250 | – | 12,939 | Form 4 |
| 2025-02-21 | Mottola FrankSVP, Quality, GMP, Ops, IT | Option exercise M | +1,125 | – | 9,576 | Form 4 |
| 2025-02-21 | Mottola FrankSVP, Quality, GMP, Ops, IT | Shares withheld for tax F | −552 | 39.15 | 9,024 | Form 4 |
| 2025-02-21 | Rubin JonathanSVP, Chief Medical Officer | Option exercise M | +1,875 | – | 8,780 | Form 4 |
| 2025-02-21 | Bhatt Padmanabh P.Sr. VP of IP, CSO | Option exercise M | +1,650 | – | 11,799 | Form 4 |
| 2025-02-21 | Bhatt Padmanabh P.Sr. VP of IP, CSO | Shares withheld for tax F | −860 | 39.15 | 10,939 | Form 4 |
| 2025-02-04 | Bhatt Padmanabh P.Sr. VP of IP, CSO | Option exercise M | +9,477 | 29.61 | 19,626 | Form 4 |
| 2025-01-28 | Bhatt Padmanabh P.Sr. VP of IP, CSO | Option exercise M | +700 | 29.61 | 10,849 | Form 4 |
| 2025-01-27 | Bhatt Padmanabh P.Sr. VP of IP, CSO | Option exercise M | +2,573 | 29.61 | 12,722 | Form 4 |
| 2025-01-22 | Hudson Frederick M.Director | Option exercise M | +20,000 | 9.13 | 48,395 | Form 4 |
| 2024-12-27 | Khattar Jack A.Director, President, CEO | Option exercise M | +38,640 | – | 964,812 | Form 4 |
| 2024-12-27 | Khattar Jack A.Director, President, CEO | Shares withheld for tax F | −18,567 | 35.59 | 946,245 | Form 4 |
| 2024-12-27 | Khattar Jack A.Director, President, CEO | Option exercise M | +14,000 | – | 960,245 | Form 4 |
| 2024-12-27 | Khattar Jack A.Director, President, CEO | Shares withheld for tax F | −6,666 | 35.59 | 953,579 | Form 4 |
| 2024-12-27 | Rubin JonathanSVP, Chief Medical Officer | Option exercise M | +750 | – | 5,822 | Form 4 |
| 2024-12-27 | Rubin JonathanSVP, Chief Medical Officer | Shares withheld for tax F | −281 | 35.59 | 5,541 | Form 4 |
| 2024-12-27 | Rubin JonathanSVP, Chief Medical Officer | Option exercise M | +1,875 | – | 7,416 | Form 4 |
| 2024-12-27 | Rubin JonathanSVP, Chief Medical Officer | Shares withheld for tax F | −821 | 35.59 | 6,595 | Form 4 |
| 2024-12-03 | Bhatt Padmanabh P.Sr. VP of IP, CSO | Option exercise M | +8,750 | 23.99 | 18,429 | Form 4 |
| 2024-12-03 | Bhatt Padmanabh P.Sr. VP of IP, CSO | Option exercise M | +12,745 | 25.30 | 22,424 | Form 4 |
| 2024-11-11 | Newhall Charles W IIIDirector | Option exercise M | +20,000 | 9.13 | 140,975 | Form 4 |
| 2024-11-08 | Khattar Jack A.Director, President, CEO | Option exercise M | +125,000 | 9.13 | 1,051,172 | Form 4 |
| 2024-11-08 | Gemayel GeorgesDirector | Option exercise M | +10,787 | 11.46 | 24,102 | Form 4 |
| 2024-11-07 | Khattar Jack A.Director, President, CEO | Option exercise M | +125,000 | 9.13 | 1,051,172 | Form 4 |
| 2024-11-07 | Gemayel GeorgesDirector | Option exercise M | +14,213 | 11.46 | 27,528 | Form 4 |
| 2024-11-07 | Mottola FrankSVP, Quality, GMP, Ops, IT | Option exercise M | +15,000 | 9.13 | 23,200 | Form 4 |
How to read it
- Buy, sale
- Code P and S on the form: shares bought or sold in the market, at the market price. The other codes are mostly pay (a grant, an option exercised) or tax (shares the company withheld), and say little about what the insider thinks of the price.
- Plan
- A sale or purchase under a Rule 10b5-1 plan, set up in advance and running on its own schedule. Since April 2023 the form has a box for it. Much executive selling is planned and says more about diversifying than about the company.
- Holds after
- The shares the insider still held after the trade, in the form the trade was in (directly, or indirectly through a trust or a fund).
- Value
- Shares times the price the form reports, which is often an average over several fills on the day.
Read from the SEC's own quarterly data sets of Forms 3, 4 and 5, and from each day's filings since the last one. A correcting amendment replaces the lines it restates. Every row links to its filing. None of this is advice: insiders sell for many reasons, and buy for fewer.